- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06268886
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease (TargetTau-1)
July 21, 2025 updated by: Bristol-Myers Squibb
A Randomized, Double-blind, Placebo-controlled, Global Proof-of-concept Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants With Early Alzheimer's Disease (TargetTau-1)
The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's Disease.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
310
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New South Wales
-
East Gosford, New South Wales, Australia, 2250
- Local Institution - 0111
-
Macquarie Park, New South Wales, Australia, 2113
- Local Institution - 0170
-
-
Queensland
-
Griffith University, Queensland, Australia, 4222
- Local Institution - 0116
-
-
Victoria
-
Carlton North, Victoria, Australia, 3053
- Local Institution - 0115
-
Ivanhoe, Victoria, Australia, 3081
- Local Institution - 0093
-
Malvern, Victoria, Australia, 3144
- Local Institution - 0001
-
Melbourne, Victoria, Australia, 03181
- Local Institution - 0125
-
Parkville, Victoria, Australia, 3050
- Local Institution - 0147
-
-
Western Australia
-
Nedlands, Western Australia, Australia, 6009
- Local Institution - 0094
-
-
-
-
-
Brussels, Belgium, 1200
- Local Institution - 0097
-
Leuven, Belgium, 3000
- Local Institution - 0076
-
-
Brussel
-
Antwerpen, Brussel, Belgium, 2018
- Local Institution - 0175
-
-
Brussels
-
Anderlecht, Brussels, Belgium, 1070
- Local Institution - 0122
-
-
VWV
-
Kortrijk, VWV, Belgium, 8500
- Local Institution - 0082
-
-
-
-
-
Quebec, Canada, G3K 2P8
- Local Institution - 0053
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Z 8R7
- Local Institution - 0112
-
Toronto, Ontario, Canada, M3B 2S7
- Local Institution - 0047
-
Toronto, Ontario, Canada, M5T 2S8
- Local Institution - 0044
-
Toronto, Ontario, Canada, M6A 2E1
- Local Institution - 0109
-
-
Quebec
-
Greenfield Park, Quebec, Canada, J4V 2J2
- Local Institution - 0113
-
Montreal, Quebec, Canada, H4A 3T2
- Local Institution - 0248
-
-
-
-
-
Chuo-Ku, Japan, 104-0031
- Local Institution - 0226
-
Himeji-shi, Japan, 670-8560
- Local Institution - 0190
-
Kasukabe-Shi, Japan, 344-0036
- Local Institution - 0188
-
Kodaira-Shi, Japan, 187-8551
- Local Institution - 0179
-
Musashimurayama-Shi, Japan, 208-0022
- Local Institution - 0221
-
Musashino-shi, Japan, 180-8610
- Local Institution - 0220
-
Nagoya-Shi, Japan, 451-0052
- Local Institution - 0180
-
Obu, Japan, 474-8511
- Local Institution - 0232
-
Osaka-shi, Japan, 545-8586
- Local Institution - 0178
-
Tachikawa-Shi, Japan, 190-0022
- Local Institution - 0240
-
Takatsuki-Shi, Japan, 569-1192
- Local Institution - 0239
-
Toyonaka-Shi, Japan, 560-0004
- Local Institution - 0189
-
-
Aichi
-
Nagoya-Shi, Aichi, Japan, 4570818
- Local Institution - 0181
-
-
Ibaraki
-
Toride-Shi, Ibaraki, Japan, 302-0004
- Local Institution - 0227
-
-
Okayama
-
Kurashiki-Shi, Okayama, Japan, 710-0813
- Local Institution - 0186
-
-
Osaka
-
Hirakata-Shi, Osaka, Japan, 573-1121
- Local Institution - 0242
-
Osaka-shi, Osaka, Japan, 556-0015
- Local Institution - 0253
-
-
Tokyo
-
Bunkyo-Ku, Tokyo, Japan, 1130034
- Local Institution - 0185
-
Hachioji-Shi, Tokyo, Japan, 192-0071
- Local Institution - 0218
-
Setagaya-Ku, Tokyo, Japan, 1588531
- Local Institution - 0184
-
-
-
-
-
Gwangjingu, Korea, Republic of, 143-729
- Local Institution - 0110
-
Incheon, Korea, Republic of, 21565
- Local Institution - 0050
-
Junggu, Korea, Republic of, 22332
- Local Institution - 0114
-
-
Seoul
-
Songpa-gu, Seoul, Korea, Republic of, 138-736
- Local Institution - 0117
-
-
-
-
-
Singapore, Singapore, 119228
- Local Institution - 0091
-
-
-
-
-
Barcelona, Spain, 08035
- Local Institution - 0171
-
Barcelona, Spain, 08003
- Local Institution - 0096
-
Barcelona, Spain, 08041
- Local Institution - 0172
-
-
B
-
Barcelona, B, Spain, 08036
- Local Institution - 0158
-
-
CT
-
Sant Cugat Del Vallès, CT, Spain, 08195
- Local Institution - 0054
-
-
L
-
Lleida, L, Spain, 25006
- Local Institution - 0231
-
-
-
-
M
-
Malmo, M, Sweden, 212 24
- Local Institution - 0167
-
-
-
-
LND
-
Enfield, LND, United Kingdom, EN3 4GS
- Local Institution - 0121
-
London, LND, United Kingdom, EC2Y 8EA
- Local Institution - 0252
-
-
SOM
-
Bath, SOM, United Kingdom, BA1 3NG
- Local Institution - 0247
-
-
Surrey
-
Chertsey, Surrey, United Kingdom, KT16 9AU
- Local Institution - 0089
-
-
-
-
Arizona
-
Chandler, Arizona, United States, 85226-3732
- Local Institution - 0068
-
Gilbert, Arizona, United States, 85297-0441
- Local Institution - 0102
-
Phoenix, Arizona, United States, 85004
- Local Institution - 0019
-
Scottsdale, Arizona, United States, 85253
- Local Institution - 0018
-
Scottsdale, Arizona, United States, 85258-4595
- Local Institution - 0026
-
Tucson, Arizona, United States, 85718-6522
- Local Institution - 0077
-
Tucson, Arizona, United States, 85718-6632
- Local Institution - 0038
-
-
California
-
Encino, California, United States, 91316-1511
- Local Institution - 0164
-
Fullerton, California, United States, 92835-1040
- Local Institution - 0139
-
Irvine, California, United States, 92614-9403
- Local Institution - 0191
-
Long Beach, California, United States, 90804-2128
- Local Institution - 0234
-
Los Alamitos, California, United States, 90720-3589
- Local Institution - 0142
-
Napa, California, United States, 94558-2415
- Local Institution - 0037
-
Sacramento, California, United States, 95816
- Local Institution - 0209
-
San Francisco, California, United States, 94143-2350
- Local Institution - 0052
-
Santa Ana, California, United States, 92705-8675
- Local Institution - 0137
-
Sherman Oaks, California, United States, 91403-2131
- Local Institution - 0046
-
-
Connecticut
-
Danbury, Connecticut, United States, 06810-4088
- Local Institution - 0106
-
New Haven, Connecticut, United States, 06510
- Local Institution - 0148
-
New Haven, Connecticut, United States, 06511-5249
- Local Institution - 0056
-
Stamford, Connecticut, United States, 06905-1206
- Local Institution - 0153
-
-
Florida
-
Altamonte Springs, Florida, United States, 32714-2436
- Local Institution - 0022
-
Atlantis, Florida, United States, 33462-6631
- Local Institution - 0048
-
Boca Raton, Florida, United States, 33428-2236
- Local Institution - 0228
-
Boca Raton, Florida, United States, 33487-3626
- Local Institution - 0250
-
Bradenton, Florida, United States, 34205
- Local Institution - 0224
-
Clermont, Florida, United States, 34711-5933
- Local Institution - 0020
-
Daytona Beach, Florida, United States, 32117-5532
- Local Institution - 0009
-
Fort Myers, Florida, United States, 33912-4302
- Local Institution - 0213
-
Greenacres City, Florida, United States, 33467
- Local Institution - 0059
-
Hialeah, Florida, United States, 33012-4170
- Local Institution - 0207
-
Hialeah, Florida, United States, 33015-5110
- Local Institution - 0212
-
Hialeah, Florida, United States, 33016-1814
- Local Institution - 0198
-
Lady Lake, Florida, United States, 32159
- Local Institution - 0151
-
Lakeland, Florida, United States, 33805-2208
- Local Institution - 0146
-
Maitland, Florida, United States, 32751
- Local Institution - 0143
-
Maitland, Florida, United States, 32751-3320
- Local Institution - 0192
-
Merritt Island, Florida, United States, 32952-3616
- Local Institution - 0027
-
Miami, Florida, United States, 33175-3598
- Local Institution - 0156
-
Miami, Florida, United States, 33032
- Local Institution - 0203
-
Miami, Florida, United States, 33122-1335
- Local Institution - 0058
-
Miami, Florida, United States, 33125-4719
- Local Institution - 0034
-
Miami, Florida, United States, 33126
- Local Institution - 0211
-
Miami, Florida, United States, 33133-4231
- Local Institution - 0195
-
Miami, Florida, United States, 33135-2957
- Local Institution - 0014
-
Miami, Florida, United States, 33135-2968
- Local Institution - 0005
-
Miami, Florida, United States, 33135-4759
- Local Institution - 0208
-
Miami, Florida, United States, 33135
- Local Institution - 0013
-
Miami, Florida, United States, 33137-2706
- Local Institution - 0008
-
Miami, Florida, United States, 33144
- Local Institution - 0199
-
Miami, Florida, United States, 33155-4630
- Local Institution - 0206
-
Miami, Florida, United States, 33155-6540
- Local Institution - 0176
-
Miami, Florida, United States, 33166-2710
- Local Institution - 0071
-
Miami, Florida, United States, 33176-2151
- Local Institution - 0249
-
Miami, Florida, United States, 33176-7947
- Local Institution - 0039
-
Miami, Florida, United States, 33176
- Local Institution - 0225
-
Miami Springs, Florida, United States, 33166-7225
- Local Institution - 0197
-
Naples, Florida, United States, 34105
- Local Institution - 0217
-
New Port Richey, Florida, United States, 34652-4020
- Local Institution - 0017
-
Ocala, Florida, United States, 34471
- Local Institution - 0144
-
Orlando, Florida, United States, 32806-8521
- Local Institution - 0202
-
Orlando, Florida, United States, 32807
- Local Institution - 0219
-
Orlando, Florida, United States, 32819-8031
- Local Institution - 0035
-
Orlando, Florida, United States, 32832
- Local Institution - 0238
-
Port Orange, Florida, United States, 32127-5170
- Local Institution - 0210
-
Sarasota, Florida, United States, 34239-3228
- Local Institution - 0204
-
Stuart, Florida, United States, 34997-6405
- Local Institution - 0136
-
Stuart, Florida, United States, 34997-5765
- Local Institution - 0012
-
Tampa, Florida, United States, 33607-6210
- Local Institution - 0200
-
Tampa, Florida, United States, 33607-6616
- Local Institution - 0080
-
Tampa, Florida, United States, 33609-4049
- Local Institution - 0087
-
Tampa, Florida, United States, 33613-4808
- Local Institution - 0042
-
Viera, Florida, United States, 32940-7948
- Local Institution - 0194
-
Wellington, Florida, United States, 33414-9320
- Local Institution - 0011
-
West Palm Beach, Florida, United States, 33409-6611
- Local Institution - 0149
-
West Palm Beach, Florida, United States, 33407-3234
- Local Institution - 0223
-
Windermere, Florida, United States, 34786-8919
- Local Institution - 0029
-
Winter Park, Florida, United States, 32792
- Local Institution - 0154
-
Winter Park, Florida, United States, 32789-1848
- Local Institution - 0101
-
-
Georgia
-
Columbus, Georgia, United States, 31909-1692
- Local Institution - 0105
-
-
Illinois
-
Chicago, Illinois, United States, 60611-2818
- Local Institution - 0236
-
Chicago, Illinois, United States, 60640-2831
- Local Institution - 0021
-
Elk Grove Village, Illinois, United States, 60007-3362
- Local Institution - 0161
-
Gurnee, Illinois, United States, 60031
- Local Institution - 0003
-
Park Ridge, Illinois, United States, 60068
- Local Institution - 0145
-
Springfield, Illinois, United States, 62702-4968
- Local Institution - 0081
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02116
- Local Institution - 0235
-
Boston, Massachusetts, United States, 02131-2515
- Local Institution - 0025
-
Braintree, Massachusetts, United States, 02184
- Local Institution - 0015
-
Foxboro, Massachusetts, United States, 02035-1309
- Local Institution - 0174
-
Methuen, Massachusetts, United States, 01844-5864
- Local Institution - 0118
-
Newton, Massachusetts, United States, 02459-3328
- Local Institution - 0040
-
Plymouth, Massachusetts, United States, 02360-7223
- Local Institution - 0120
-
Watertown, Massachusetts, United States, 02472-4153
- Local Institution - 0045
-
-
New Hampshire
-
Portsmouth, New Hampshire, United States, 03801-6822
- Local Institution - 0119
-
-
New Jersey
-
Princeton, New Jersey, United States, 08540-2859
- Local Institution - 0031
-
Toms River, New Jersey, United States, 08755-5043
- Local Institution - 0062
-
-
New York
-
Albany, New York, United States, 12208-3464
- Local Institution - 0060
-
Amherst, New York, United States, 14226-1727
- Local Institution - 0157
-
Manhasset, New York, United States, 11030-3816
- Local Institution - 0061
-
New York, New York, United States, 10029-5611
- Local Institution - 0205
-
New York, New York, United States, 10029-5611
- Local Institution - 0214
-
New York, New York, United States, 10029-6504
- Local Institution - 0104
-
New York, New York, United States, 10032-3726
- Local Institution - 0133
-
-
North Carolina
-
Matthews, North Carolina, United States, 28105-8336
- Local Institution - 0043
-
-
Ohio
-
Dayton, Ohio, United States, 45459-4296
- Local Institution - 0215
-
Independence, Ohio, United States, 44131
- Local Institution - 0155
-
-
Pennsylvania
-
Plymouth Meeting, Pennsylvania, United States, 19462-7401
- Local Institution - 0023
-
-
Rhode Island
-
East Providence, Rhode Island, United States, 02914
- Local Institution - 0024
-
Providence, Rhode Island, United States, 02906-4800
- Local Institution - 0163
-
-
Tennessee
-
Cordova, Tennessee, United States, 38018-4254
- Local Institution - 0132
-
Franklin, Tennessee, United States, 37067-5922
- Local Institution - 0140
-
Nashville, Tennessee, United States, 37212
- Local Institution - 0222
-
-
Texas
-
Austin, Texas, United States, 78757-8046
- Local Institution - 0069
-
Beaumont, Texas, United States, 77702
- Local Institution - 0033
-
Dallas, Texas, United States, 75231-4316
- Local Institution - 0051
-
Houston, Texas, United States, 77074-1812
- Local Institution - 0016
-
-
Virginia
-
Fairfax, Virginia, United States, 22031-5216
- Local Institution - 0196
-
Richmond, Virginia, United States, 23294
- Local Institution - 0168
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria
- Mild cognitive impairment (MCI) due to Alzheimer's disease (AD) or mild AD dementia consistent with the National Institute on Aging and the Alzheimer's Association (NIA-AA) core clinical criteria.
- Global Clinical Dementia Rating (CDR) score of 0.5 to 1.0 and a CDR-Memory Box score of 0.5 and greater at screening and Baseline.
- Evidence of AD pathology.
- Objective impairment in episodic memory as indicated by at least 1 standard deviation below age-adjusted mean in the Wechsler Memory Scale IV-Logical Memory Subtest II (WMS-IV LM II).
- Mini Mental Status Examination (MMSE) score ≥ 20 to 28 (inclusive).
Exclusion Criteria
- Any evidence of a condition that may affect cognition other than AD.
- Contraindications to PET imaging.
- Inability to tolerate or contraindication to magnetic resonance imaging.
- Any serious medical condition that could, in the opinion of the investigator, affect the participant's safety or interfere with study assessments.
- Geriatric Depression Scale (GDS) score greater than or equal to 8 at screening.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Specified dose on specified days
|
|
Experimental: BMS-986446 Dose A
|
Specified dose on specified days
|
|
Experimental: BMS-986446 Dose B
|
Specified dose on specified days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in brain tau deposition as measured by tau positron emission tomography (PET)
Time Frame: At week 76
|
At week 76
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score
Time Frame: At week 76
|
At week 76
|
|
Change from baseline in integrated Alzheimer's Disease Rating Scale (iADRS) score
Time Frame: At week 76
|
At week 76
|
|
Change from baseline in Alzheimer's Disease Assessment Scale-Cognitive subscale (ADASCog14) score
Time Frame: At week 76
|
At week 76
|
|
Change from baseline in Alzheimer's Disease Cooperative Study-instrumental Activities of Daily Living scale (ADCS-iADL) score
Time Frame: At week 76
|
At week 76
|
|
Change from baseline in Mini Mental State Examination (MMSE) score
Time Frame: At week 76
|
At week 76
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Bristol-Myers Squibb, Bristol-Myers Squibb
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 20, 2024
Primary Completion (Estimated)
March 18, 2027
Study Completion (Estimated)
March 18, 2027
Study Registration Dates
First Submitted
February 13, 2024
First Submitted That Met QC Criteria
February 13, 2024
First Posted (Actual)
February 20, 2024
Study Record Updates
Last Update Posted (Actual)
July 24, 2025
Last Update Submitted That Met QC Criteria
July 21, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CN008-0003
- U1111-1290-3539 (Registry Identifier: WHO)
- 2023-504840-32 (Other Identifier: EU CTR)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria.
Additional information regarding Bristol Myers Squibb's data sharing policy and process can be found at:
https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosurecommitment.html
IPD Sharing Time Frame
See Plan Description
IPD Sharing Access Criteria
See Plan Description
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease, Early Onset
-
Alnylam PharmaceuticalsRecruitingEarly-Onset Alzheimer DiseaseUnited States, Netherlands, Canada, United Kingdom
-
Mayo ClinicActive, not recruitingEarly Onset Alzheimer DiseaseUnited States
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Denali Therapeutics Inc.RecruitingAlzheimer Disease, Early OnsetUnited Kingdom
-
Massachusetts Institute of TechnologyRecruitingAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Alzheimer'sUnited States
-
University of MiamiColumbia University; National Institute on Aging (NIA); Case Western Reserve... and other collaboratorsCompletedDementia | Mild Cognitive Impairment | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Dementia of Alzheimer TypeUnited States
-
ElMindA LtdUnknownDepression | Aging | Mild Cognitive Impairment | Early Onset Alzheimer DiseaseUnited States
-
Arrowhead PharmaceuticalsRecruitingAlzheimer Disease | Alzheimer Disease, Early OnsetNew Zealand, Canada
-
Swiss Federal Institute of TechnologyAlzheimer's Drug Discovery FoundationRecruiting
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of